VANCOUVER, BC and PRINCETON, N.J. JAN 24, 2022 Xybion Digital (XYBN-TSXV), a global, low-code SaaS company that enables digital transformation in highly regulated industries like Life Sciences, announced today it has been selected by Stira Pharmaceuticals to digitize their R&D and Manufacturing labs to enhance process efficiency and improve compliance. Xybion’s Labwise XD LIMS and ELN solutions will be implemented to standardize and digitize Stira’s lab operations as part of its digital transformation journey.
“We are excited to partner with Xybion for expertise and SaaS software to help with our digital transformation journey. We want to operate in the best-in-class digital work environment and platform based, cloud software such as Labwise XD provides an immense value to execute our digital strategy,” says Dr. Satya Valiveti, CEO, Stira Pharmaceuticals.
Labwise XD LIMS is a modular, unified, and all-inclusive end-to-end LIMS SaaS platform to support all workflows in the labs. This manages Test Methods, Sample Management, Stability Studies, Inventory Management, Analytical Methods, Instrument Management, Lab Personnel Training & Safety, Quality Management and ELN to create a unified Digital Lab Execution System. This comes with a Customer Portal that helps create a seamless communication mechanism between two companies without downloading information out of Labwise XD. Labwise XD is also available to manage Gene & Cell Therapy Labs and Manufacturing Operations. Xybion has been named as one of the top 10 Laboratory Information Management System (LIMS) Solution providers by Pharma Tech Outlook in their annual publication.
“Digital solutions should be simple, easy-to-implement, manage and improve the productivity, efficiency and compliance of any lab. Labwise XD is a cloud-based lab management solution, very nimble and easy to implement. This also reduces the burden of buying and integrating multiple systems to meet the business and compliance requirements of any lab operations. This will help Stira digitize its labs very quickly and creates a faster ROI,” says Kamal Biswas, President & COO of Xybion Digital Inc.
About Stira Pharmaceuticals
Stira Pharmaceuticals is a Research and development company dedicated to developing and commercializing specialty Injectable generic pharmaceuticals. Stira Pharma also provides contract analytical services to small and large pharma companies. Incorporated in 2019 and using in house facilities and capabilities, Stira Pharmaceuticals is currently developing number specialty generic products for US market.
Learn more about Stira at https://www.stirapharma.com/about.php
About Xybion Corporation
Xybion is the leading provider of software, services and consulting for global corporations operating in highly regulated industries. Xybion specializes in the development and delivery of flexible enterprise solutions that can be easily configured, integrated or deployed out of the box to deliver the capabilities you need.
Xybion is dedicated to helping corporations solve business problems and create new capabilities. Through intelligently designed systems and business processes, we help companies become more efficient, reduce costs and manage compliance, regulatory adherence and risk.
Serving more than 160 customers in 25 countries, we have the global scale and expertise to bring employees around the world to help companies in life sciences, healthcare, manufacturing, workplace health, and government.
We put our expertise in action every day to help companies transform the digital workplace. Our unique solutions focus on regulatory compliance, quality laboratory control, quality assurance, digital lab solution, workforce training, content management.
Since its founding in 1977, Xybion Corporation has supported, through software, services, and consulting, most of the top 20 global life sciences companies.
Learn more about Xybion at: https://www.xybion.com/